Literature DB >> 34413272

Personalized Sepsis Treatment: Are We There Yet?

Shreya M Kanth1, Parizad Torabi-Parizi.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34413272      PMCID： PMC8381969          DOI： 10.1097/CCM.0000000000005116

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   9.296


× No keyword cloud information.
  16 in total

Review 1.  Immune Exhaustion and Transplantation.

Authors:  A Sanchez-Fueyo; J F Markmann
Journal:  Am J Transplant       Date:  2016-02-16       Impact factor: 8.086

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559).

Authors:  Richard S Hotchkiss; Elizabeth Colston; Sachin Yende; Derek C Angus; Lyle L Moldawer; Elliott D Crouser; Greg S Martin; Craig M Coopersmith; Scott Brakenridge; Florian B Mayr; Pauline K Park; June Ye; Ian M Catlett; Ihab G Girgis; Dennis M Grasela
Journal:  Crit Care Med       Date:  2019-05       Impact factor: 7.598

4.  T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.

Authors:  Miguel Fribourg; Lisa Anderson; Clara Fischman; Chiara Cantarelli; Laura Perin; Gaetano La Manna; Adeeb Rahman; Bryna E Burrell; Peter S Heeger; Paolo Cravedi
Journal:  Kidney Int       Date:  2019-02-27       Impact factor: 10.612

5.  Inhibitory Immune Checkpoint Molecule Expression in Clinical Sepsis Studies: A Systematic Review.

Authors:  Lindsay M Busch; Junfeng Sun; Peter Q Eichacker; Parizad Torabi-Parizi
Journal:  Crit Care Med       Date:  2020-09       Impact factor: 7.598

6.  Expression of Exhaustion Markers on CD8+ T-Cell Patterns Predict Outcomes in Septic Patients Admitted to the ICU.

Authors:  Damien Guinault; Marie-Laure Nicolau-Travers; Stein Silva; Olivier Cointault; Barnabé Daniau; Arnaud Del Bello; Michael Peres; David Rousset; Julie Rieunier; Laurence Lavayssiere; Marie-Béatrice Nogier; Edith Hourcastagnou; Arnaud Mari; Nassim Kamar; François Vergez; Stanislas Faguer
Journal:  Crit Care Med       Date:  2021-04-22       Impact factor: 7.598

7.  Unplanned Readmissions After Hospitalization for Severe Sepsis at Academic Medical Center-Affiliated Hospitals.

Authors:  John P Donnelly; Samuel F Hohmann; Henry E Wang
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

8.  Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab.

Authors:  Richard S Hotchkiss; Elizabeth Colston; Sachin Yende; Elliott D Crouser; Greg S Martin; Timothy Albertson; Raquel R Bartz; Scott C Brakenridge; Matthew J Delano; Pauline K Park; Michael W Donnino; Mark Tidswell; Florian B Mayr; Derek C Angus; Craig M Coopersmith; Lyle L Moldawer; Ian M Catlett; Ihab G Girgis; June Ye; Dennis M Grasela
Journal:  Intensive Care Med       Date:  2019-10-01       Impact factor: 17.440

Review 9.  Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions.

Authors:  Fabienne Venet; Alain Lepape; Guillaume Monneret
Journal:  Crit Care       Date:  2011-10-07       Impact factor: 9.097

Review 10.  Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.

Authors:  Margaret A McBride; Tazeen K Patil; Julia K Bohannon; Antonio Hernandez; Edward R Sherwood; Naeem K Patil
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.